Alzheimer's disease seeded tau forms paired helical filaments yet lacks seeding potential

被引:3
|
作者
Duan, Pu [1 ]
Dregni, Aurelio J. [1 ]
Xu, Hong [2 ,3 ]
Changolkar, Lakshmi [2 ,3 ]
Lee, Virginia M. Y. [2 ,3 ]
Lee, Edward B. [4 ]
Hong, Mei [1 ]
机构
[1] MIT, Dept Chem, Cambridge, MA 02139 USA
[2] Univ Penn, Inst Aging, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Philadelphia, PA USA
[4] Univ Penn, Dept Pathol & Lab Med, Translat Neuropathol Res Lab, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
PROTEIN-TAU; PROPAGATION; PATHOLOGY; STRAINS; DIVERSITY; PRIONS;
D O I
10.1016/j.jbc.2024.107730
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease (AD) and many other neurodegenerative diseases are characterized by pathological aggregation of the protein tau. These tau aggregates spread in a stereotypical spatiotemporal pattern in the brain of each disease, suggesting that the misfolded tau can recruit soluble monomers to adopt the same pathological structure. To investigate whether recruited tau indeed adopts the same structure and properties as the original seed, here we template recombinant full-length 0N3R tau, 0N4R tau, and an equimolar mixture of the two using sarkosyl-insoluble tau extracted from AD brain and determine the structures of the resulting fibrils using cryoelectron microscopy. We show that these cell-free amplified tau fibrils adopt the same molecular structure as the AD paired-helical filament (PHF) tau but are unable to template additional monomers. Therefore, the PHF structure alone is insufficient for defining the pathological properties of AD tau, and other biochemical components such as tau posttranslational modifications, other proteins, polyanionic cofactors, and salt are required for the prion-like serial propagation of tauopathies.
引用
收藏
页数:12
相关论文
共 35 条
  • [31] Tau protein: A potential biological indicator for early recognition of Alzheimer's disease [Tau-protein: Ein potentieller biologischer Indikator zur Fruherkennung der Alzheimer-Krankheit]
    Buch K.
    Riemenschneider M.
    Bartenstein P.
    Willoch F.
    Müller U.
    Schmolke M.
    Nolde T.
    Steinmann C.
    Guder W.G.
    Kurz A.
    Der Nervenarzt, 1998, 69 (5) : 379 - 385
  • [32] Spatially pathogenic forms of tau detected in Alzheimer's disease brain tissue by fluorescence lifetime-based Forster resonance energy transfer
    Larionov, Sergey
    Wielgat, Przemyslaw
    Wang, Yiner
    Thal, Dietmar Rudolf
    Neumann, Harald
    JOURNAL OF NEUROSCIENCE METHODS, 2010, 192 (01) : 127 - 137
  • [33] High-affinity antibodies specific to the core region of the tau protein exhibit diagnostic and therapeutic potential for Alzheimer's disease
    Arastoo, Mohammad
    Penny, Lewis K.
    Lofthouse, Richard
    Abdallah, Aya
    Abrahamsson, Anna
    Marini, Pietro
    Melis, Valeria
    Riedel, Gernot
    Harrington, Charles R.
    Wischik, Claude M.
    Porter, Andrew
    Palliyil, Soumya
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [34] Native PLGA nanoparticles attenuate Aβ-seed induced tau aggregation under in vitro conditions: potential implication in Alzheimer's disease pathology
    Paul, Pallabi Sil
    Patel, Tark
    Cho, Jae-Young
    Yarahmady, Allan
    Khalili, Aria
    Semenchenko, Valentyna
    Wille, Holger
    Kulka, Marianna
    Mok, Sue-Ann
    Kar, Satyabrata
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [35] Colocalization of Phosphorylated Forms of WAVE1, CRMP2, and Tau in Alzheimer's Disease Model Mice: Involvement of Cdk5 Phosphorylation and the Effect of ATRA Treatment
    Watamura, Naoto
    Toba, Junya
    Yoshii, Aya
    Nikkuni, Miyu
    Ohshima, Toshio
    JOURNAL OF NEUROSCIENCE RESEARCH, 2016, 94 (01) : 15 - 26